Inhibikase Therapeutics, Inc. Quarterly Current Ratio in % from Q2 2023 to Q4 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Inhibikase Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2023 to Q4 2024.
  • Inhibikase Therapeutics, Inc. Current Ratio for the quarter ending December 31, 2024 was 736 %, a 4.74% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2024 736 +33.3 +4.74% Dec 31, 2024
Q3 2024 232 -541 -70% Sep 30, 2024
Q2 2024 362 -466 -56.3% Jun 30, 2024
Q1 2024 491 Mar 31, 2024
Q4 2023 703 Dec 31, 2023
Q3 2023 773 Sep 30, 2023
Q2 2023 829 Jun 30, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.